Reeve Emma bought PTCT
September 11, 2025 · Form 4 insider transaction
Reeve Emma bought 837 shares of PTC Therapeutics, Inc. at $33.63 per share, a transaction worth $28.1K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 5 days after the transaction.
Direction
Acquired (buy-side)
Shares
837
Price
$33.63
Total value
$28.1K
InsiderReeve Emma
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateSeptember 11, 2025
Filing dateSeptember 16, 2025
Shares owned after11,169
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on March 4, 2025.